Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis

NCT02391506 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-03-22

No results posted yet for this study

Summary

This study will evaluate whether Cartiva is an effective treatment for individuals with osteoarthritis of the CMC joint in the hand.

Conditions

Interventions

DEVICE

Cartiva

Cartiva Synthetic Cartilage Implant

Sponsors & Collaborators

  • Cartiva, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-29
Primary Completion
2019-03-05
Completion
2019-03-05

Countries

  • Canada
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02391506 on ClinicalTrials.gov